ReviewThe Journal of experimental medicine2026

Follow the "DOTs": Vδ1+ γδ T cells as effectors of cancer immunotherapy.

Bruno Silva-Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.